Form D · Pharmaceuticals
ABBOTT LABORATORIES
Abbott Park, IL · CIK 0000001800
Offering snapshot reported Mar 15, 2011 · SEC filing
- Reported sold
- $100K Offering amount: $100K
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $1K Reported outside-investor minimum
- First sale
- Mar 1, 2011 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 15, 2011 | Initial | $100,000 | No comparison | 1 | SEC filing |
| Mar 12, 2010 | Initial | $70,000 | No comparison | 1 | SEC filing |
| Mar 13, 2009 | Initial | $6,690,000 | No comparison | Not reported | SEC filing |
| Mar 17, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Mar 15, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Mar 24, 2006 | Paper | Not reported | No comparison | Not reported |
Offering details
- Securities
- Debt
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $200
- Finders' fees
- $0
- Form D file number
- 021-156765
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Goldman Sachs & Co. | 361 |
Source: Form D, filed Mar 15, 2011. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Carlos Alban | Executive |
| Robert J. Alpern | Director |
| Richard W. Ashley | Executive |
| Roxanne S. Austin | Director |
| Brian J. Blaser | Executive |
| Olivier Bohuon | Executive |
| John M. Capek | Executive |
| Thomas F. Chen | Executive |
| William M. Daley | Director |
| W. James Farrell | Director |
| A. David Forrest | Executive |
| Thomas C. Freyman | Executive |
| H. Laurance Fuller | Director |
| Stephen R. Fussell | Executive |
| Richard A. Gonzalez | Executive |
| Robert B. Hance | Executive |
| John C. Landgraf | Executive |
| Edward M. Liddy | Director |
| Holger A. Liepmann | Executive |
| Greg W. Linder | Executive |
| Heather L. Mason | Executive |
| James V. Mazzo | Executive |
| Edward L. Michael | Executive |
| Phebe N. Novakovic | Director |
| William A. Osborn | Director |
| David A.L. Owen | Director |
| Donald V. Patton Jr. | Executive |
| Boone Powell Jr. | Director |
| W. Ann Reynolds | Director |
| Roy S. Roberts | Director |
| Laura J. Schumacher | Executive |
| Samuel C. Scott Iii | Director |
| William D. Smithburg | Director |
| Mary T. Szela | Executive |
| Glenn F. Tilton | Director |
| James L. Tyree | Executive |
| Michael J. Warmuth | Executive |
| J. Scott White | Executive |
| Miles D. White | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
100 Abbott Park Road
Abbott Park, IL, 60064-3500
Abbott Park, IL, 60064-3500